Results for tag: "Gallbladder Neoplasm Drug"

Gallbladder neoplasm is a type of cancer that affects the gallbladder, a small organ located in the upper right abdomen. It is a rare form of cancer, accounting for only 1-2% of all gastrointestinal cancers. Treatment for gallbladder neoplasm typically involves a combination of surgery, chemotherapy, and radiation therapy. Oncology drugs are used to treat cancer, including gallbladder neoplasm. These drugs can be used to reduce the size of tumors, reduce the spread of cancer cells, and reduce the side effects of other treatments. Commonly used oncology drugs include monoclonal antibodies, targeted therapies, and immunotherapies. The market for oncology drugs for gallbladder neoplasm is relatively small, due to the rarity of the disease. However, there are a number of companies that are developing and marketing drugs for this condition. These include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more